Heart Rate Variability Monitoring Using a Wearable Armband

A wearable electrocardiogram (ECG) monitor is evaluated as heart rate variability (HRV) monitor. The device consists of an armband designed to be worn on the left upper arm which provides 3 ECG channels based on 3 pairs of dry (no hydrogel) electrodes. Armband-ECG and conventional-Holter-ECG signals were simultaneously recorded from 14 subjects during 5 minutes in supine position. Spacial principal component analysis was used to obtain a unique armband ECG signal in which the electromyogram contribution is attenuated. QRS complexes were automatically detected. Five traditional HRV parameters were derived: SDNN, RMSSD, pNN50, and powers within low frequency (LF, [0.04, 0.15] Hz) and high frequency (HF, [0.15, 0.4] Hz) bands. The Pearson''s correlation coefficient between the measurements from the armband device and the measures from the Holter device was computed. Results show very high correlations (1.0000, 0.9999, 0.9984, 1.0000, and 0.9999 for SDNN, RMSSD, pNN50, and powers at LF and HF, respectively), suggesting that the quality of armband-ECG signals is enough to estimate HRV parameters during stationary movement restricted conditions

Electrocardiogram Derived Respiration for Tracking Changes in Tidal Volume from a Wearable Armband

A pilot study on tracking changes in tidal volume (TV) using ECG signals acquired by a wearable armband is presented. The wearable armband provides three ECG channels by using three pairs of dry electrodes, resulting in a device that is convenient for long-term daily monitoring. An additional ECG channel was derived by computing the first principal component of the three original channels (by means of principal component analysis). Armband and spirometer signals were simultaneously recorded from five healthy subjects who were instructed to breathe with varying TV. Three electrocardiogram derived respiration (EDR) methods based on QRS complex morphology were studied: the QRS slopes range (SR), the R-wave angle (), and the R-S amplitude (RS). The peak-to-peak amplitudes of these EDR signals were estimated as surrogates for TV, and their correlations with the reference TV (estimated from the spirometer signal) were computed. In addition, a multiple linear regression model was calculated for each subject, using the peak-to-peak amplitudes from the three EDR methods from the four ECG channels. Obtained correlations between TV and EDR peak-to-peak amplitude ranged from 0.0448 up to 0.8491. For every subject, a moderate correlation (>0.5) was obtained for at least one EDR method. Furthermore, the correlations obtained for the subject-specific multiple linear regression model ranged from 0.8234 up to 0.9154, and the goodness of fit was 0.73±0.07 (median ± standard deviation). These results suggest that the peak-to-peak amplitudes of the EDR methods are linearly related to the TV. opening the possibility of estimating TV directly from an armband ECG device.Clinical Relevance - This opens the door to possible continuous monitoring of TV from the armband by using EDR

Optical Evidence of Multiphase Coexistence in Single Crystalline (La,Pr,Ca)MnO3

We investigated temperature (T)- and magnetic field-dependent optical conductivity spectra (\s\w) of a La_5/8-yPr_yCa_3/8MnO_3 (y~0.35) single crystal, showing intriguing phase coexistence at low T. At T_C < T < T_CO, a dominant charge-ordered phase produces a large optical gap energy of ~0.4 eV. At T < T_C, at least two absorption bands newly emerge below 0.4 eV. Analyses of (\s\w) indicate that the new bands should be attributed to a ferromagnetic metallic and a charge-disordered phase that coexist with the charge-ordered phase. This optical study clearly shows that La_5/8-yPrCa_3/8MnO_3 (y~0.35) is composed of multiphases that might have different lattice strains.Comment: A single file with 9 figures embedded, to appear in Phys. Rev.

Melting of Charge/Orbital Ordered States in Nd1/2_{1/2}Sr1/2_{1/2}MnO3_3: Temperature and Magnetic Field Dependent Optical Studies

We investigated the temperature ($T=$ 15 $\sim$ 290 K) and the magnetic field ($H=$ 0 $\sim$ 17 T) dependent optical conductivity spectra of a charge/orbital ordered manganite, Nd$_{1/2}$Sr$_{1/2}$MnO$_3$. With variation of $T$ and $H$, large spectral weight changes were observed up to 4.0 eV. These spectral weight changes could be explained using the polaron picture. Interestingly, our results suggested that some local ordered state might remain above the charge ordering temperature, and that the charge/orbital melted state at a high magnetic field (i.e. at $H=$ 17 T and $$ 4.2 K) should be a three dimensional ferromagnetic metal. We also investigated the first order phase transition from the charge/orbital ordered state to ferromagnetic metallic state using the $T$- and $H$% -dependent dielectric constants $\epsilon_1$. In the charge/orbital ordered insulating state, $\epsilon_1$ was positive and $d\epsilon_1/d\omega \approx 0$. With increasing $T$ and $H$, $\epsilon_1$ was increased up to the insulator-metal phase boundaries. And then, $\epsilon_1$ abruptly changed into negative and $d\epsilon_1/d\omega >0$, which was consistent with typical responses of a metal. Through the analysis of $\epsilon_1$ using an effective medium approximation, we found that the melting of charge/orbital ordered states should occur through the percolation of ferromagnetic metal domains.Comment: submitted to Phys. Rev.

Optical Investigations of Charge Gap in Orbital Ordered La1/2Sr3/2MnO4

Temperature and polarization dependent electronic structure of La1/2Sr3/2MnO4 were investigated by optical conductivity analyses. With decreasing temperature, for E//ab, a broad mid-infrared (MIR) peak of La1/2Sr3/2MnO4 becomes narrower and moves to the higher frequency, while that of Nd1/2Sr3/2MnO4 nearly temperature independent. We showed that the MIR peak in La1/2Sr3/2MnO4 originates from orbital ordering associated with CE-type magnetic ordering and that the Jahn-Teller distortion has a significant influence on the width and the position of the MIR peak.Comment: 10 pages, 4 figure

Dimensional Crossover driven by Magnetic Ordering in Optical Conductivity of Pr_{1/2}Sr_{1/2}MnO_3

We investigated optical properties of Pr_{0.5}Sr_{0.5}MnO_3, which has the A-type antiferromagnetic ordering at a low temperature. We found that T- dependence of spectral weight transfer shows a clear correlation with the magnetic phase transition. In comparison with the optical conductivity results of Nd_{0.5}Sr_{0.5}MnO_3, which has the CE-type antiferromagnetic charge ordering, we showed that optical properties of Pr_{0.5}Sr_{0.5}MnO_3 near the Neel temperature could be explained by a crossover from 3D to 2D metals. Details of spectral weight changes are consistent with the polaron picture.Comment: 11 pages, 4 figures, submitted to PRL at June

Temperature-dependent Raman spectroscopy in BaRuO3_3 systems

We investigated the temperature-dependence of the Raman spectra of a nine-layer BaRuO$_3$ single crystal and a four-layer BaRuO$_3$ epitaxial film, which show pseudogap formations in their metallic states. From the polarized and depolarized spectra, the observed phonon modes are assigned properly according to the predictions of group theory analysis. In both compounds, with decreasing temperature, while $A_{1g}$ modes show a strong hardening, $E_g$ (or $E_{2g}$) modes experience a softening or no significant shift. Their different temperature-dependent behaviors could be related to a direct Ru metal-bonding through the face-sharing of RuO$_6$. It is also observed that another $E_{2g}$ mode of the oxygen participating in the face-sharing becomes split at low temperatures in the four layer BaRuO$_3$. And, the temperature-dependence of the Raman continua between 250 $\sim$ 600 cm$^{-1}$ is strongly correlated to the square of the plasma frequency. Our observations imply that there should be a structural instability in the face-shared structure, which could be closely related to the pseudogap formation of BaRuO$_3$ systems.Comment: 8 pages, 6 figures. to be published in Phys. Rev.

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362